Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Provizor Federal was a U.S. healthcare staffing and government contracting company focused on supplying clinicians and allied health professionals to federal agencies, military treatment facilities, and other government healthcare settings. The company operated as a wholly owned subsidiary of Provizor Solutions and rebranded from OMV Medical to Provizor Federal in 2022. Its service offerings centered on contract staffing across nursing, pharmacy, radiology, therapy, laboratory, psychiatry, psychology, social services, critical care, and other specialty healthcare functions rather than on drug development. Although it had an established operating history dating back to 1987 and generated commercial staffing revenue, the business filed for Chapter 7 bankruptcy in February 2024. Available deal databases indicate the company was subsequently acquired or merged in August 2024, but public details on the acquirer and transaction value are not clearly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Provizor Federal.